Flinn Foundation Awards TGen Additional $9 Million
News Oct 13, 2005
The Translational Genomics Research Institute (TGen) has announced the receipt of a $9 million unrestricted grant from the Flinn Foundation designed to help accelerate research discoveries across a broad spectrum of diseases.
The Phoenix-based Flinn Foundation had awarded the largest private gift to establish TGen in 2002; this grant brings the Foundation's total commitment to $24 million.
One third of this most recent grant will serve as a match challenge for the TGen Foundation's Naming Campaign.
“TGen is well on its way to meeting the ambitious expectations outlined by Arizona public and private leaders when it was created,” said John Murphy, Flinn Foundation President and CEO.
“Its track record has been remarkable in achieving genomic discoveries, generating federal grants, and forging close partnerships with Arizona’s universities and research institutions.”
“This grant celebrates those achievements and recognizes TGen's importance in building Arizona's competitiveness in the biosciences economy.”
In 2002, the Foundation funded a comprehensive study by the Battelle Memorial Institute that outlined a 10-year roadmap to "fast track" Arizona on a path to achieve national bioscience stature and a diversified economy.
The study highlighted Arizona's existing research strengths and emphasized the need for increased public- and private-sector collaboration.
“The Flinn Foundation is playing a leading role in catalyzing Arizona's charge in the biosciences,” said Dr. Jeffrey Trent, President and Scientific Director of TGen.
“This grant will allow TGen to pursue a number of initiatives that should greatly influence our research capacity. The fact that the grant is unrestricted indicates the Flinn's belief that as an institute, TGen is on the right track.”
The announcement of the Flinn award was initially made at the Silverleaf dinner hosted by noted Valley leaders Jacquie and Bennett Dorrance and the TGen Foundation.
One third of the Flinn award, or $3 million, will be used as a dollar-for-dollar challenge fund for the TGen Foundation"s Naming Initiative.
This allows donors to make a lasting contribution to research by naming spaces within TGen such as laboratory benches, conference rooms, and other areas.
“We are delighted that Jacquie and Bennett Dorrance are again leading the effort to secure funding for TGen's research initiatives,” said Michael Bassoff, President of the TGen Foundation.
“This year, with an eye toward attracting a new family of contributors, there will be opportunities for donors to make gifts directly to the research program of their choice.”
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.